Pathogenic Mechanisms of HHV-8 ORF74
Pathogenic Mechanisms of HHV-8 ORF74
批准号:
6770183
负责人:
MARVIN S REITZ
金额:
$29.74万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-06-30
关键词:
Kaposi&aposs sarcomaapoptosiscell adhesion moleculescell linecellular oncologychemokine receptorhuman herpesvirus 8human immunodeficiency virus 1laboratory mouseluciferin monooxygenaseneoplastic growthoncoproteinsopen reading framesphosphatidylinositol 3 kinasephosphorylationprotein protein interactionserine threonine protein kinasetranscription factortransfectionviral carcinogenesisvirus infection mechanismvirus proteinvirus related neoplasm /cancervirus virus interaction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Considerable evidence implicates human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma herpesvirus (KSHV), as the necessary etiologic agent of Kaposi's sarcoma (KS). Although the mechanisms of KS pathogenesis by HHV-8 are not well understood, recent evidence suggests that expression of paracrine factors by cells undergoing lytic phase viral replication is important. The HHV-8 chemokine receptor homologue ORF74, a lytic phase gene product, activates several signaling pathways in the absence of added ligand, including NFkB, NF-AT and AP-1, and induces the expression of pro-inflammatory cytokines and cell adhesion molecules. We hypothesize that activation of NFkappaB, NF-AT and AP-1 depends on signaling via the PI-3 kinase-Akt pathway and causes the expression of pro-inflammatory factors, and that chronic dysregulated expression of these factors eventually results in tumor formation. Co-infection with HIV-1 is an extremely strong risk factor for KS development. We hypothesize that the Tat protein of HIV-1 synergizes with ORF74 in activating NFkappaB, NF-AT and AP-1 through the PI-3 kinase-Akt pathway and enhances ORF74-mediated tumorigenesis. The central hypothesis is that Akt is the key mediator of these ORF74-dependent processes. To test these hypotheses, we will characterize ORF74 activation of NFKappaB, NF-AT and AP-1 and induction of pro-inflammatory and anti-apoptotic factors via PI-3 kinase-Akt and will determine whether ORF74-mediated tumorigenesis in a mouse model depends on activation of NFkappaB, NFAT and AP-1 via PI-3 kinase-Akt and GSK-3. We will also determine whether Tat augments ORF74 activation of NFkappaB, NF-AT and AP-1 via PI-3 kinase-Akt and GSK-3 and enhances ORF74 tumorigenesis in mice. These studies should provide valuable insights on the contribution of ORF74 to KS pathogenesis and show a mechanism by which HIV-1 cooperates with HHV-8 in causing KS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of Ritonavir on HHV-8 vGPCR signaling and tumorigenesis
-
批准号:7491371
-
项目类别:
-
资助金额:$13.84万
-
财政年份:2006
-
负责人:MARVIN S REITZ
-
依托单位:
Effects of Ritonavir on HHV-8 vGPCR signaling and tumorigenesis
-
批准号:7163346
-
项目类别:
-
资助金额:$16.93万
-
财政年份:2006
-
负责人:MARVIN S REITZ
-
依托单位:
Pathogenic Mechanisms of HHV-8 ORF74
-
批准号:6913724
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2003
-
负责人:MARVIN S REITZ
-
依托单位:
Pathogenic Mechanisms of HHV-8 ORF74
-
批准号:7489138
-
项目类别:
-
资助金额:$28.19万
-
财政年份:2003
-
负责人:MARVIN S REITZ
-
依托单位:
Pathogenic Mechanisms of HHV-8 ORF74
-
批准号:7089023
-
项目类别:
-
资助金额:$29.04万
-
财政年份:2003
-
负责人:MARVIN S REITZ
-
依托单位:
Pathogenic Mechanisms of HHV-8 ORF74
-
批准号:6695201
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2003
-
负责人:MARVIN S REITZ
-
依托单位:
Pathogenic Mechanisms of HHV-8 ORF74
-
批准号:7225500
-
项目类别:
-
资助金额:$0.29万
-
财政年份:2003
-
负责人:MARVIN S REITZ
-
依托单位:
HHV-8 AND KAPOSI'S SARCOMA
-
批准号:6311553
-
项目类别:
-
资助金额:$15.41万
-
财政年份:2000
-
负责人:MARVIN S REITZ
-
依托单位:
HHV-8 AND KAPOSI'S SARCOMA
-
批准号:6203470
-
项目类别:
-
资助金额:$15.41万
-
财政年份:1999
-
负责人:MARVIN S REITZ
-
依托单位:
CHEMOKINE RECEPTOR EXPRESSION IN LYMPHOCYTES
-
批准号:2887747
-
项目类别:
-
资助金额:$7.43万
-
财政年份:1998
-
负责人:MARVIN S REITZ
-
依托单位:
CHEMOKINE RECEPTOR EXPRESSION IN LYMPHOCYTES
-
批准号:2650111
-
项目类别:
-
资助金额:$7.45万
-
财政年份:1998
-
负责人:MARVIN S REITZ
-
依托单位:
CORE--VIROLOGY
-
批准号:6100237
-
项目类别:
-
资助金额:$9.44万
-
财政年份:1998
-
负责人:MARVIN S REITZ
-
依托单位:
HHV-8 AND KAPOSI'S SARCOMA
-
批准号:6103518
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:MARVIN S REITZ
-
依托单位:
HHV-6 IN AIDS--MECHANISMS OF CD4 GENE ACTIVATION
-
批准号:2423531
-
项目类别:
-
资助金额:$7.25万
-
财政年份:1997
-
负责人:MARVIN S REITZ
-
依托单位:
HHV-6 IN AIDS--MECHANISMS OF CD4 GENE ACTIVATION
-
批准号:2673090
-
项目类别:
-
资助金额:$7.25万
-
财政年份:1997
-
负责人:MARVIN S REITZ
-
依托单位:
海外基金